Decursin and decursinol angelate from Angelica gigas Nakai induce apoptosis via induction of TRAIL expression on cervical cancer cells

European Journal of Integrative Medicine

Volumn 3, Issue 4, 2011, Pages e299-e307

  Yim, Nam Hui ^a   Lee, Ju Hye ^a   Cho, Won Kyung ^a   Yang, Min Chul ^a   Kwak, Dong Hoon ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Angelica gigas nakai; Apoptosis; Cervical cancer cells; Decursin; Decursinol angelate; TRAIL

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGELICA GIGAS EXTRACT; APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; CASPASE; CASPASE 8; CASPASE 9; PROTEIN BCL 2; PROTEIN BCL X; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

ANGELICA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ASSAY; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 82455162401     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2011.09.007     Document Type: Article

References (40)

1. Son S.H., Park K.K., Park S.K., Kim Y.C., Kim Y.S., Chung W.Y., et al. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma. Phytother Res 2010, 25:959-964.
2. Konoshima M., Chi H.J., Hata K. Courmarins from the root of Angelica gigas. Chem Pharm Bull 1968, 16:1139-1140.
3. Moon C.K., Lee S.C., Yun Y.P., Ha B.J., Yook C.S. Effects of some coumarin derivatives on the bovine lens aldose reductase activity. Arch Pharmacol Res 1988, 11:308-311.
4. Kang S.Y., Kim Y.C. Decursinol and decursin protect primary cultured rat cortical cells from glutamate induced neurotoxicity. J Pharm Pharmacol 2007, 59:863-870.
5. Kang S.Y., Lee K.Y., Sung S.H., Kim Y.C. Four new neuroprotective dihydropyrano-coumarins from Angelica gigas. J Nat Prod 2005, 68:56-59.
6. Lee Y.Y., Lee S.S., Jin J.L., Yun-Choi H.S. Platelet anti-aggregatory effects of courmarinsfrom the roots of Angelica genuflexa and A. gigas. Arch Pharmacol Res 2003, 26:723-726.
7. Bae E.A., Han M.J., Kim N.J., Kim D.H. Anti-helicobacter pylori activity of herbal medicines. Biol Pharm Bull 1998, 21:990-992.
8. Lee S., Shin D.S., Kim J.S., Oh K.B., Kang S.S. Antibacterial courmarins from Angelica gigas roots. Arch Pharmacol Res 2003, 26:449-452.
9. Ahn K.S., Sim W.S., Kim I.H. Detection of anticancer activity from the root of Angelica gigas in vitro. J Microbiol Biotechnol 1995, 5:105-109.
10. Itokawa H., Yun H., Morita H., Takeya K., Lee S.R. Cytotoxic courmarins from roots of Angelica gigas Nakai. Nat Med 1994, 48:334-335.
11. Lee S., Lee Y.S., Jung S.H., Shin K.H., Kim B.K., Kang S.S. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Arch Pharmacol Res 2003, 26:727-730.
12. Kim D.H., Kim D.Y., Kim Y.C., Jung J.W., Lee S., Ryu J.H., et al. Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice. Life Sci 2007, 80:1944-1950.
13. Jung M.H., Lee S.H., Ahn E.M., Lee Y.M. Decursin and decursinol angelate inhibit VEGF induced angiogenesis via suppression of the VEGFR-2 signaling pathway. Carcinogenesis 2009, 30:655-661.
14. Son S.H., Kim M.J., Chung W.Y., Son J.A., Kim Y.S., Park K.K., et al. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett 2009, 280:86-92.
15. Jiang C., GuoJ, Wang Z., Xiao B., Lee H.J., Le J., et al. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells. Breast Cancer Res 2007, 9:R:77.
16. Lü J., Kim S.H., Jiang C., Lee H., Guo J. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents. Acta Pharmacol Sin 2007, 28:1365-1372.
17. Chou S.Y., Hsu C.S., Hsu M.Y., Liang S.J., Yeh C.L., Yeh S.L. Effects of different arginine concentration on angiogenic protein production induced by HeLa cells. Nutrition 2010, 26:818-822.
18. Naidoo S., Raidoo D.M. Angiogenesis in cervical cancer is mediated by HeLa metabolites through endothelial cell tissue kallikrein. Oncol Rep 2009, 22:285-293.
19. Li L., Bu S., Bäckström T., Landström M., Ulmstem U., Fu X. Induction of apoptosis andG2/M arrest by 2-methoxyesteradiol in human cervical cancer HeLaS3 cells. Anticancer Res 2004, 24:873-880.
20. Monk B.J., Tewari K.S., Koh W.J. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007, 25:2952-2965.
21. Debatin K.M., Poncet D., Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 2002, 21:8786-8803.
22. Lewanski C.R., Gullick W.J. Radiotherapy and cellular signaling. Lancet Oncol 2001, 2:366-370.
23. Wu G.S. TRAIL as a target in anti-cancer therapy. Cancer Lett 2009, 285:1-5.
24. Humphreys R.C., Halpern W. Trail receptors: targets for cancer therapy. Adv Exp Med Biol 2008, 615:127-158.
25. Yagita H., Takeda K., Hayakawa Y., Smyth M.J., Okumura K. TRAIL and its receptors as targets for cancer therapy. Cancer Sci 2004, 95:777-783.
26. Sheikh M.S., Huang Y. Death receptors as targets of cancer therapeutics. Curr Cancer Drug Targets 2004, 4:97-104.
27. Belka C., Schmid B., Marini P., Durand E., Rudner J., Budach W., et al. Sensitization of resistant lymphoma cells to irradiation induced apoptosis by the death ligand TRAIL. Oncogene 2001, 20:2190-2196.
28. Yim D., Singh R.P., Agarwal C., Lee S., Chi H., Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 2005, 65:1035-1044.
29. Weon J.B., Park H., Yang H.J., Ma J.Y., Ma C.J. Simultaneous quantification of marker components in Ojeok-san by HPLC-DAD. J Nat Med 2011, 65:375-380.
30. Kopnin B.P. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis. Biochemistry 2000, 65:2-27.
31. Chung K.S., Yim N.H., Lee S.H., Choi S.J., Hur K.S., Won M.S. Identification of small molecules inducing apoptosis by cell-based assay using fission yeast deletion mutans. Invest New Drugs 2008, 26:299-307.
32. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis 2000, 21:485-495.
33. Desagher S., Martinou J.C. Mitocondria as the central control point of apoptosis. Trends Cell Biol 2000, 10:369-377.
34. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002, 296:1635-1636.
35. Jin Z., El-Deiry W.S Overview of cell death signaling pathways. Cancer Biol Ther 2005, 4:139-163.
36. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev 1999, 13:239-252.
37. Sun X.M., Bartton S.B., Butterworth M., MacFarlane M., Cohen G.M. Bcl-2 CD95-mediate apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 2002, 277:11345-11351.
38. Roberts D.L., Merrison W., MacFarlane M., Cohen G.M. The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity. J Cell Biol 2001, 153:221-228.
39. MacFarlane M., Merrison W., Bratton S.B., Cohen G.M. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 2002, 277:36611-36616.
40. Park R.J., Kim N.J., Lee K.T., Seo S.H. Comparative studies on concentration of decursinol in plasma after oral administration of Angelica gigantis radix extract and combined use of decursin and Cnidii rhizome extract or Bupleuri radix extract in rats. Korean J Pharmacogn 2001, 32:72-78.